Bristol-Myers Squibb Company (BMY) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Bristol-Myers Squibb Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 15.61x | -12.81x | 13.23x | 24.22x | 19.80x | -15.57x |
| P/B Ratio | 5.96x | 7.02x | 3.61x | 4.93x | 3.85x | 3.70x |
| P/S Ratio | 2.28x | 2.37x | 2.36x | 3.32x | 2.99x | 3.29x |
| Profitability | ||||||
| Gross Margin | 67.6% | 56.8% | 56.3% | 57.4% | 57.7% | 51.0% |
| Operating Margin | 26.3% | 20.0% | 18.8% | 20.1% | 20.6% | 10.6% |
| Net Margin | 14.6% | -18.5% | 17.8% | 13.7% | 15.1% | -21.2% |
| EBITDA Margin | 30.2% | 6.6% | 43.0% | 41.6% | 43.4% | 11.6% |
| Liquidity | ||||||
| Current Ratio | 1.26x | 1.25x | 1.43x | 1.25x | 1.52x | 1.58x |
| Quick Ratio | 1.14x | 1.15x | 1.31x | 1.14x | 1.43x | 1.47x |
| Leverage | ||||||
| Debt/Equity | 2.55x | 3.13x | 1.41x | 1.31x | 1.27x | 1.37x |
YoY = year-over-year change. Source: FMP..